Abstract
Chemokines are a class of low-molecular-weight proteins that induce chemotaxis and are implicated in the modulation of angiogenesis. The imbalance among angiogenic and antiangiogenic chemokines can promote the development of several conditions, including chronic inflammation, dysplastic transformation and cancer. In this review, we describe the activity and clinical significance of chemokines in prostate and renal tumors and provide an update on ongoing studies in this setting.
Keywords:
angiogenesis; chemokines; prostate cancer; renal cancer.
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Chemokines / antagonists & inhibitors
-
Chemokines / genetics
-
Chemokines / metabolism*
-
Female
-
Gene Expression Regulation, Neoplastic
-
Humans
-
Immunotherapy
-
Kidney Neoplasms / drug therapy
-
Kidney Neoplasms / genetics
-
Kidney Neoplasms / metabolism*
-
Kidney Neoplasms / pathology
-
Lymphocytes / immunology
-
Lymphocytes / metabolism
-
Male
-
Molecular Targeted Therapy
-
Neovascularization, Pathologic / metabolism
-
Prostatic Neoplasms / drug therapy
-
Prostatic Neoplasms / genetics
-
Prostatic Neoplasms / metabolism*
-
Prostatic Neoplasms / pathology
-
Receptors, Chemokine / metabolism
-
Signal Transduction
Substances
-
Antineoplastic Agents
-
Chemokines
-
Receptors, Chemokine